CEOs of the research-based pharmaceutical industry issued a stark warning to President von der Leyen that unless Europe delivers rapid, radical policy change then pharmaceutical research, development and manufacturing is increasingly likely to be directed towards the US.

Read more here.

At the core of PPPs lies the recognition that no single sector nor stakeholder has the comprehensive capabilities required to tackle the multifaceted challenges inherent in healthcare research. By strategically combining their respective strengths, public and private entities can collectively achieve outcomes that would be unattainable through individual efforts.

Read the full report here.

Discover the conect4children (c4c) project: a large, collaborative pan-European network aiming to optimise the delivery of clinical trials in children.

Watch the video below to learn more about this initiative.